Retrospective Cohort Study
Copyright ©The Author(s) 2019.
World J Gastrointest Oncol. Apr 15, 2019; 11(4): 310-321
Published online Apr 15, 2019. doi: 10.4251/wjgo.v11.i4.310
Table 1 Baseline characteristics on patients
TIPS-125I group(n = 40)TIPS only group(n = 45)P-value
Gender0.961
Male2730
Female1315
Average age51 ± 4.349 ± 6.90.311
Etiology0.923
Hepatitis B or C2428
Alcoholic87
Cholestasis46
Other44
Child-Push classification0.384
A610
B2016
C1419
Albumin (g/L)30 ± 1132 ± 110.915
Direct bilirubin (umol/L)23.1 ± 16.921 ± 150.43
Alanine aminotransferase (U/L)49 ± 3653 ± 410.756
Aspartate aminotransferase (U/L)42.5 ± 26.550.5 ± 37.50.318
Na+135.5 ± 15.5138.5 ± 16.50.384
K+3.73 ± 1.273.49 ± 1.310.609
MELD score11.96 ± 1.6812.77 ± 2.490.187
Clinical symptoms0.486
Hemorrhage2932
Chest and/or abdominal dropsy65
Both58
First-grade branch of portal vein0.571
Unobstructed1822
Obstructed2223
Table 2 The portosystemic pressure gradient before and after transjugular intrahepatic portosystemic shunt was significantly different in the two groups
PPG before TIPS (mmHg)PPG after TIPS (mmHg)NumbertdfP-valueSD of differenceSEM of differenceR squared
TIPS-125I group26.96 ± 5.7313.1 ± 5.94020.8839< 0.00014.3670.69050.9179
TIPS only group26.12 ± 512.6 ± 5.44522.94440.00024.0890.60960.9228
Table 3 The rates of symptom recurrence, stent restenosis and survival during follow-up
TIPS-125I groupTIPS only groupP-value
Rate of stent stenosis< 0.05
6 mo12.542.2
12 mo27.568.9
24 mo42.584.4
Rate of symptom recurrence< 0.05
6 mo7.531.1
12 mo22.562.2
24 mo3582.2
Survival rate< 0.05
6 mo8064.4
12 mo4524.4
24 mo204.4
Table 4 The multivariate analysis of survival
Univariate analysis
Multivariate analysis
HR95%CIP-valueHR95%CIP-value
Group1.9431.219-3.0970.0052.6311.603-4.318< 0.001
MELD score1.0420.849-1.2790.6921.6971.261-2.282< 0.001
DBIL0.9880.965-1.0120.3380.161
ALT0.9910.979-1.0030.1500.078
Child-Pugh classification< 0.001< 0.001
B/A1.5460.793-3.0160.2013.7831.718-8.329
C/A3.4931.764-6.918< 0.00113.875.192-37.07